NCT05544929 2026-01-06
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Phase 1 Active not recruiting
Novartis
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
DEKA Biosciences
Emory University
Nimbus Therapeutics